MH Guide - Pathfinder for genome-based therapy planning

MH Guide interprets complex molecular analyses and helps you recommend evidence-based treatments for your cancer patients

Translate molecular data into precision medicine

MH Guide is an analysis software that supports molecular pathologists and oncologists in the interpretation of large molecular datasets. Independent of the sequencing technology used, MH Guide can make complex NGS datasets readable, and automatically identify genetic variants that are relevant for treating cancer patients. This information is translated into clinical knowledge that helps you make individual therapy decisions.

How attending physicians benefit from MH Guide:

• Comprehensive information on relevant biomarkers and their clinical significance

• Information on treatment options, especially for cancer patients with advanced disease, with rare diseases, or for those who have exhausted the options of standard therapy

• Information on relevant clinical trials for your patients

• Information on possible side effects, drug-drug interactions, or drug resistance

• A digital platform for interdisciplinary case discussion in molecular tumor boards

Your treatment decision, supported by worldwide clinical evidence

The MH Guide process

Diagnostic and molecular pathology laboratories use our software-based in-vitro diagnostic application MH Guide to identify relevant biomarkers in tumor samples, and to provide attending physicians with information on individual treatment and trial options. The software compares the patient sample data with current, published biomedical knowledge and drug data.

MH Guide provides pertinent information about identified, relevant biomarkers and their clinical significance in the respective cancer entities. All of this information is summarized in a clear patient report. This way, you receive key information on effective and safe drug treatment options and available clinical trials – entirely in line with precision medicine.